Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

OncoPlex Diagnostics

OncoPlex Diagnostics?uq=UG6efJS6
2001 FOUNDED
M&A STATUS
21-30 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Provider of clinical proteomics and genetic mutation for the treatment of cancer patient. The company provides proprietary technology to solubilize tumor cell proteins from FFPE tissue for quantitation by mass spectrometry analysis.

Formerly Known As
Expression Pathology
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Therapeutic Devices
Biotechnology
Acquirer
Primary Office
  • 9600 Medical Center Drive
  • Suite 300
  • Rockville, MD 20850
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore OncoPlex Diagnostics’s full profile, request a free trial.

OncoPlex Diagnostics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 10-Sep-2015 Completed Generating Revenue
1. Later Stage VC 01-Jan-2008 0000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

OncoPlex Diagnostics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Maryland Venture Fund Venture Capital Minority 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0
VentureCross Partners Venture Capital Minority 000 0000 000000 0

OncoPlex Diagnostics Executive Team (5)

Name Title Board
Seat
Contact
Info
Todd Hembrough Ph.D President, Proteomics, Chief Scientific Officer, Vice President & Head of Research and Development
Linda Broenniman Chief Financial Officer
Thomas Guiel Chief Operating Officer & Executive Vice President
Jedd Levine MD Chief Medical Officer

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »